The indications for radiation therapy are those features that put the patient at risk for local recurrence after surgical resection. These factors include narrow or positive surgical margins, local recurrence after prior surgery, tumor size of >5 cm, lesions deep to or invading the superficial fascia, high grade, and younger than 50 years (20). BT monotherapy as an adjuvant can be considered in patients with high-grade sarcomas of the extremity or superficial trunk if they have undergone complete

surgical excision with negative margins (8). There is no consensus on whether BT should be combined with EBRT selleck compound in the setting of positive margins or whether one modality is sufficient. Early data from Memorial Sloan-Kettering Cancer Center (MSKCC) showed that combined BT and EBRT had better LC for patients with positive margins (9), but in subsequent reports that difference was not observed (21). Factors that may influence the use of EBRT and BT in scenarios with positive margins include the tumor grade, prior surgeries, and tumor size (22). BT in combination with external beam is recommended for cases with recurrent disease who have not been previously irradiated [10], [23], [24] and [25]. The location of the primary sarcoma appears to impact the clinical

outcome, and it may affect treatment planning considerations for radiation therapy. Studies indicate that there may be differences in tumor control rates and morbidity between upper and lower extremity lesions as well as extremity vs. truncal lesions. Talazoparib manufacturer The MSKCC group evaluated patients treated with either EBRT or BT and found that the upper extremity was associated with a greater rate of local recurrence compared with the lower extremity (26) independent of tumor size, depth, and margin status. Their group also noted ifoxetine the shoulder

location as an independent prognostic factor for poor LC (8). Several BT series report increased toxicity in the lower limb compared with the upper limb [23], [27] and [28]. Sensitive locations such as the hands also have increased toxicity with radiation compared with surgery alone. In a retrospective review of 55 patients with STS of the hands, 26 had radiation with EBRT alone (21 patients) or combined with BT (5 patients). The complication rate was higher in the radiation cohort compared with the surgical cohort (19/26 vs. 3/29), and all 5 patients who underwent BT developed complications. The placement of BT catheters adjacent to finger joints seemed to be associated with complications (29). These studies indicate that for distal extremity (acral) lesions meticulous attention to treatment technique is warranted. The clinical circumstances, implant volume, target dose, timing of treatment, and other technical details of BT can have significant impact on outcome and must be carefully assessed before treatment.